Verrica Pharmaceuticals
VRCA
NASDAQ
IPO2018
about VRCA
Verrica Pharmaceuticals is a biopharmaceutical company focused on developing innovative topical treatments for common urological and dermatological conditions, including warts and other skin-related disorders.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $5.56 | $6.79 | $5.50 | $48.59M | 1.16M |
| eps |
price to earnings |
price to sales |
operating margin |
profit margin |
yield |
| -$0.03 | n/a | 4.50 | 11.34% | -1.91% | 0% |